Detalhe da pesquisa
1.
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
Adv Sci (Weinh)
; 11(13): e2305212, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263873